1. Home
  2. CNK vs KNSA Comparison

CNK vs KNSA Comparison

Compare CNK & KNSA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Cinemark Holdings Inc Cinemark Holdings Inc.

CNK

Cinemark Holdings Inc Cinemark Holdings Inc.

HOLD

Current Price

$28.89

Market Cap

3.4B

ML Signal

HOLD

Logo Kiniksa Pharmaceuticals Ltd.

KNSA

Kiniksa Pharmaceuticals Ltd.

HOLD

Current Price

$42.35

Market Cap

3.5B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
CNK
KNSA
Founded
1984
2015
Country
United States
United Kingdom
Employees
N/A
N/A
Industry
Movies/Entertainment
Biotechnology: Pharmaceutical Preparations
Sector
Consumer Discretionary
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
3.4B
3.5B
IPO Year
2007
2018

Fundamental Metrics

Financial Performance
Metric
CNK
KNSA
Price
$28.89
$42.35
Analyst Decision
Buy
Strong Buy
Analyst Count
10
7
Target Price
$33.70
$56.00
AVG Volume (30 Days)
1.8M
547.5K
Earning Date
05-01-2026
04-28-2026
Dividend Yield
1.19%
N/A
EPS Growth
N/A
225.00
EPS
1.04
0.75
Revenue
$3,115,000,000.00
$677,564,000.00
Revenue This Year
$11.01
$37.60
Revenue Next Year
$3.70
$17.77
P/E Ratio
$29.08
$57.07
Revenue Growth
2.15
60.09
52 Week Low
$21.60
$20.24
52 Week High
$34.01
$50.03

Technical Indicators

Market Signals
Indicator
CNK
KNSA
Relative Strength Index (RSI) 49.85 32.66
Support Level $27.24 $41.98
Resistance Level $29.17 $42.91
Average True Range (ATR) 1.04 1.97
MACD -0.13 -0.66
Stochastic Oscillator 37.82 10.07

Price Performance

Historical Comparison
CNK
KNSA

About CNK Cinemark Holdings Inc Cinemark Holdings Inc.

Cinemark Holdings Inc is a geographically diverse operator in the motion picture exhibition industry in the United States. The company generates revenue from filmed entertainment box office receipts and concession sales, with additional revenue from screen advertising, screen rentals, and other revenue streams, such as transactional fees, vendor marketing promotions, studio trailer placements, meeting rentals, and electronic video games located in some of the theatres. Cinemark manages its business under two reportable segments: U.S. markets and international markets. The majority of its revenue is generated from the U.S. markets segment.

About KNSA Kiniksa Pharmaceuticals Ltd.

Kiniksa Pharmaceuticals International PLC is a clinical-stage biopharmaceutical company focused on discovering, acquiring, developing, and commercializing therapeutic medicines for patients suffering from debilitating cardiovascular diseases. The company's clinical-stage product candidates include Rilonacept, abiprubart, and Vixarelimab. Geographically, the company earns maximum revenue from United States.

Share on Social Networks: